Opioid Induced Constipation Drugs Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4144692
- 114 Pages
- December 2020
- Healthcare
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Opioid Induced Constipation Drugs market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Opioid Induced Constipation Drugs market segmented into
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Others
Based on the end-use, the global Opioid Induced Constipation Drugs market classified into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Based on geography, the global Opioid Induced Constipation Drugs market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Ironwood Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Pfizer
Progenics Pharmaceuticals Inc
Shionogi & Co., Ltd
Allergan Plc
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma AG
Mundipharma International Limited
Ono Pharmaceutical Co., Ltd
Takeda Pharmaceutical Company Limited
Theravance Biopharma Inc
Valeant Pharmaceuticals International
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL OPIOID INDUCED CONSTIPATION DRUGS INDUSTRY
2.1 Summary about Opioid Induced Constipation Drugs Industry
2.2 Opioid Induced Constipation Drugs Market Trends
2.2.1 Opioid Induced Constipation Drugs Production & Consumption Trends
2.2.2 Opioid Induced Constipation Drugs Demand Structure Trends
2.3 Opioid Induced Constipation Drugs Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Lubiprostone
4.2.2 Methyl Naltrexone Bromide
4.2.3 Naldemedine
4.2.4 Alvimopan
4.2.5 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospital Pharmacies
4.3.2 Retail Pharmacies
4.3.3 Online Pharmacies
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Lubiprostone
5.2.2 Methyl Naltrexone Bromide
5.2.3 Naldemedine
5.2.4 Alvimopan
5.2.5 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospital Pharmacies
5.3.2 Retail Pharmacies
5.3.3 Online Pharmacies
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Lubiprostone
6.2.2 Methyl Naltrexone Bromide
6.2.3 Naldemedine
6.2.4 Alvimopan
6.2.5 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospital Pharmacies
6.3.2 Retail Pharmacies
6.3.3 Online Pharmacies
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Lubiprostone
7.2.2 Methyl Naltrexone Bromide
7.2.3 Naldemedine
7.2.4 Alvimopan
7.2.5 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospital Pharmacies
7.3.2 Retail Pharmacies
7.3.3 Online Pharmacies
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Lubiprostone
8.2.2 Methyl Naltrexone Bromide
8.2.3 Naldemedine
8.2.4 Alvimopan
8.2.5 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospital Pharmacies
8.3.2 Retail Pharmacies
8.3.3 Online Pharmacies
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Lubiprostone
9.2.2 Methyl Naltrexone Bromide
9.2.3 Naldemedine
9.2.4 Alvimopan
9.2.5 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospital Pharmacies
9.3.2 Retail Pharmacies
9.3.3 Online Pharmacies
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Ironwood Pharmaceuticals Inc
10.1.2 Daiichi Sankyo Co Ltd
10.1.3 Pfizer
10.1.4 Progenics Pharmaceuticals Inc
10.1.5 Shionogi & Co., Ltd
10.1.6 Allergan Plc
10.1.7 Nektar Therapeutics
10.1.8 Purdue Pharma
10.1.9 S.L.A. Pharma AG
10.1.10 Mundipharma International Limited
10.1.11 Ono Pharmaceutical Co., Ltd
10.1.12 Takeda Pharmaceutical Company Limited
10.1.13 Theravance Biopharma Inc
10.1.14 Valeant Pharmaceuticals International
10.1.15 Cosmo Pharmaceuticals SA
10.1.16 Daewoong Pharmaceutical
10.1.17 C.B. Fleet Company
10.1.18 Sucampo Pharmaceuticals
10.2 Opioid Induced Constipation Drugs Sales Date of Major Players (2017-2020e)
10.2.1 Ironwood Pharmaceuticals Inc
10.2.2 Daiichi Sankyo Co Ltd
10.2.3 Pfizer
10.2.4 Progenics Pharmaceuticals Inc
10.2.5 Shionogi & Co., Ltd
10.2.6 Allergan Plc
10.2.7 Nektar Therapeutics
10.2.8 Purdue Pharma
10.2.9 S.L.A. Pharma AG
10.2.10 Mundipharma International Limited
10.2.11 Ono Pharmaceutical Co., Ltd
10.2.12 Takeda Pharmaceutical Company Limited
10.2.13 Theravance Biopharma Inc
10.2.14 Valeant Pharmaceuticals International
10.2.15 Cosmo Pharmaceuticals SA
10.2.16 Daewoong Pharmaceutical
10.2.17 C.B. Fleet Company
10.2.18 Sucampo Pharmaceuticals
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
Table Opioid Induced Constipation Drugs Product Type Overview
Table Opioid Induced Constipation Drugs Product Type Market Share List
Table Opioid Induced Constipation Drugs Product Type of Major Players
Table Brief Introduction of Ironwood Pharmaceuticals Inc
Table Brief Introduction of Daiichi Sankyo Co Ltd
Table Brief Introduction of Pfizer
Table Brief Introduction of Progenics Pharmaceuticals Inc
Table Brief Introduction of Shionogi & Co., Ltd
Table Brief Introduction of Allergan Plc
Table Brief Introduction of Nektar Therapeutics
Table Brief Introduction of Purdue Pharma
Table Brief Introduction of S.L.A. Pharma AG
Table Brief Introduction of Mundipharma International Limited
Table Brief Introduction of Ono Pharmaceutical Co., Ltd
Table Brief Introduction of Takeda Pharmaceutical Company Limited
Table Brief Introduction of Theravance Biopharma Inc
Table Brief Introduction of Valeant Pharmaceuticals International
Table Brief Introduction of Cosmo Pharmaceuticals SA
Table Brief Introduction of Daewoong Pharmaceutical
Table Brief Introduction of C.B. Fleet Company
Table Brief Introduction of Sucampo Pharmaceuticals
Table Products & Services of Ironwood Pharmaceuticals Inc
Table Products & Services of Daiichi Sankyo Co Ltd
Table Products & Services of Pfizer
Table Products & Services of Progenics Pharmaceuticals Inc
Table Products & Services of Shionogi & Co., Ltd
Table Products & Services of Allergan Plc
Table Products & Services of Nektar Therapeutics
Table Products & Services of Purdue Pharma
Table Products & Services of S.L.A. Pharma AG
Table Products & Services of Mundipharma International Limited
Table Products & Services of Ono Pharmaceutical Co., Ltd
Table Products & Services of Takeda Pharmaceutical Company Limited
Table Products & Services of Theravance Biopharma Inc
Table Products & Services of Valeant Pharmaceuticals International
Table Products & Services of Cosmo Pharmaceuticals SA
Table Products & Services of Daewoong Pharmaceutical
Table Products & Services of C.B. Fleet Company
Table Products & Services of Sucampo Pharmaceuticals
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Opioid Induced Constipation Drugs Market Forecast (Million USD) by Region 2021f-2026f
Table Global Opioid Induced Constipation Drugs Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Opioid Induced Constipation Drugs Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Opioid Induced Constipation Drugs Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
